| Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ... JAMA oncology 5 (8), 1124-1131, 2019 | 674 | 2019 |
| Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ... Journal of Clinical Oncology 37 (18), 1547-1557, 2019 | 396 | 2019 |
| Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence RC Coombes, K Page, R Salari, RK Hastings, A Armstrong, S Ahmed, ... Clinical Cancer Research 25 (14), 4255-4263, 2019 | 376 | 2019 |
| ctDNA guiding adjuvant immunotherapy in urothelial carcinoma T Powles, ZJ Assaf, N Davarpanah, R Banchereau, BE Szabados, ... Nature 595 (7867), 432-437, 2021 | 350 | 2021 |
| Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study AP Kater, JQ Wu, T Kipps, B Eichhorst, P Hillmen, J D’rozario, S Assouline, ... Journal of Clinical Oncology 38 (34), 4042, 2020 | 188 | 2020 |
| Pairing centers recruit a Polo-like kinase to orchestrate meiotic chromosome dynamics in C. elegans NC Harper, R Rillo, S Jover-Gil, ZJ Assaf, N Bhalla, AF Dernburg Developmental cell 21 (5), 934-947, 2011 | 141 | 2011 |
| An actin cytoskeleton with evolutionarily conserved functions in the absence of canonical actin-binding proteins AR Paredez, ZJ Assaf, D Sept, L Timofejeva, SC Dawson, CJR Wang, ... Proceedings of the National Academy of Sciences 108 (15), 6151-6156, 2011 | 98 | 2011 |
| Molecular determinants of response to PD-L1 blockade across tumor types R Banchereau, N Leng, O Zill, E Sokol, G Liu, D Pavlick, S Maund, LF Liu, ... Nature communications 12 (1), 3969, 2021 | 95 | 2021 |
| Nuclear inheritance and genetic exchange without meiosis in the binucleate parasite Giardia intestinalis ML Carpenter, ZJ Assaf, S Gourguechon, WZ Cande Journal of cell science 125 (10), 2523-2532, 2012 | 76 | 2012 |
| Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder B Szabados, M Kockx, ZJ Assaf, PJ van Dam, A Rodriguez-Vida, I Duran, ... European urology 82 (2), 212-222, 2022 | 71 | 2022 |
| Early detection of residual breast cancer through a robust, scalable and personalized analysis of circulating tumour DNA (ctDNA) antedates overt metastatic recurrence RC Coombes, A Armstrong, S Ahmed, K Page, RK Hastings, R Salari, ... Cancer Res 79, P4-01, 2019 | 59 | 2019 |
| The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogens BA Wilson, NR Garud, AF Feder, ZJ Assaf, PS Pennings Molecular ecology 25 (1), 42-66, 2016 | 50 | 2016 |
| Deep sequencing of natural and experimental populations of Drosophila melanogaster reveals biases in the spectrum of new mutations ZJ Assaf, S Tilk, J Park, ML Siegal, DA Petrov Genome research 27 (12), 1988-2000, 2017 | 41 | 2017 |
| Naegleria gruberi De Novo Basal Body Assembly Occurs via Stepwise Incorporation of Conserved Proteins LK Fritz-Laylin, ZJ Assaf, S Chen, WZ Cande Eukaryotic cell 9 (6), 860-865, 2010 | 37 | 2010 |
| A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer ZJF Assaf, W Zou, AD Fine, MA Socinski, A Young, D Lipson, JF Freidin, ... Nature Medicine 29 (4), 859-868, 2023 | 35 | 2023 |
| Blood first assay screening trial (BFAST) in treatment-naive advanced or metastatic NSCLC: initial results of the phase 2 ALK-positive cohort R Dziadziuszko, T Mok, S Peters, JY Han, J Alatorre-Alexander, N Leighl, ... Journal of Thoracic Oncology 16 (12), 2040-2050, 2021 | 32 | 2021 |
| Obstruction of adaptation in diploids by recessive, strongly deleterious alleles ZJ Assaf, DA Petrov, JR Blundell Proceedings of the National Academy of Sciences 112 (20), E2658-E2666, 2015 | 31 | 2015 |
| 1O Clinical outcomes in post-operative ctDNA-positive muscle-invasive urothelial carcinoma (MIUC) patients after atezolizumab adjuvant therapy TB Powles, ZJ Assaf, N Davarpanah, M Hussain, S Oudard, JE Gschwend, ... Annals of Oncology 31, S1417, 2020 | 27 | 2020 |
| Circulating tumor DNA (ctDNA) dynamics associate with treatment response and radiological progression-free survival (rPFS): Analyses from a randomized phase II trial in … J Goodall, ZJ Assaf, Z Shi, G Seed, L Zhang, B Lauffer, W Yuan, ... Journal of Clinical Oncology 38 (15_suppl), 5508-5508, 2020 | 14 | 2020 |
| LBA1 Final analysis of the placebo-controlled randomised phase III IMpassion031 trial evaluating neoadjuvant atezolizumab (atezo) plus chemotherapy (CT) followed by open-label … C Barrios, N Harbeck, HA Zhang, S Saji, KH Jung, R Hegg, A Koehler, ... ESMO Open 8 (1), 2023 | 9 | 2023 |
